Menopause
News
Women on Denosumab Maintain Bone Benefits After 5 Years
Clinical Review
UPDATE ON MENOPAUSE
Here is a roundup of the latest data on vitamin D requirements in women and how the route, timing, and duration of hormone therapy influence its...
Expert Commentary
Is hormone therapy still a valid option? 12 ObGyns address this question
Clinicians understand the risks and benefits of hormone therapy for menopausal women more precisely than ever—but has the pendulum swung too far...
From the Editor
Consider denosumab for postmenopausal osteoporosis
Easy to use and effective, this recently approved agent appears well suited to ObGyn office practice
Expert Commentary
Can nonhormonal treatments relieve hot flushes in breast Ca survivors?
Yes. A Cochrane Review found clonidine, selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs),...
Article
Breast cancer prevention and Tx: An evidence-based guide
When to begin screening mammography may be the latest controversy, but it’s not the only uncertainty regarding breast health and cancer care. We’...
Expert Commentary
At what thickness is the endometrial stripe cause for concern in a woman who has postmenopausal bleeding?
4 mm. That is the cutoff recommended by ACOG. However, the authors of this systematic review and meta-analysis propose a new cutoff: 3 mm....
News for Your Practice
New study reveals a link between estrogen-progestin HRT and advanced breast cancer
Data from the Women’s Health Initiative show that mortality is higher in postmenopausal women who develop breast cancer after taking combined...
News for Your Practice
In the aftermath of the WHI, consider estrogen patient by patient
The Women’s Health Initiative wrought a sea change in attitudes toward menopausal estrogen therapy. According to Isaac Schiff, MD, estrogen is...
Clinical Review
UPDATE: MENOPAUSE
We’re learning more about the long-term risks and benefits of hormone therapy, how to assess and treat osteoporosis, and the need for vitamin D